In this book, a group of leading world-renowned clinicians and editors, Dr. Manish Aghi and Dr. Lewis Blevins, give us a guide to medical decision-making on diagnosing and treating patients with acromegaly. The goal of this publication was to construct a book that was different from any other on acromegaly.
Acroline™ is a series of four brochures created by Pfizer in collaboration with an international panel of people with acromegaly, acromegaly support groups, and health psychologists. This series of supportive guides and tools are designed to help keep your life on track and live well with acromegaly.
Well, it looks like Diabetes Insipidus is on the way out, at least from the naming point of view. After the work done in Basel (Universitätsspital Basel), recently published in The Lancet, an international consensus group proposed a name change from Diabetes Insipidus to Arginine Vasopressin Deficiency or AVP-D, or Arginine Vasopressin Resistance or AVP-R, depending on the type.
From the editors: In what is now a yearly occurrence, pituitary groups and industry from all over the world mark October as pituitary awareness month. “The hope in doing this work is to organize a joint effort to maximize the opportunity to talk with a unified voice and increase awareness of pituitary diseases,” said JD Faccinetti, Chairman and chief editor of Pituitary World News.
From the University of California, San Francisco, (UCSF) MedConnection comes a fascinating article about a patient with a giant pituitary adenoma removed via endoscopic endonasal surgery.
We continue to showcase Pfizer’s new series on patient support. This brochure offers great advice on how to deal with a new acromegaly diagnosis. The materials provide valuable content given the importance of proper disease
We are excited to announce that, beginning early in 2022, Pituitary World News will go live with a weekly radio show! Stay tuned for an announcement with final details, schedules, and times. We are in